Safety study of a new drug in healthy adults
This early-stage study tests a new investigational drug (called WD-910) in healthy volunteers to see how safe it is, how the body processes it, and how it affects the body. You would receive either the drug or a placebo (a pill with no active medicine), and doctors will monitor you closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your body mass index (BMI) is between 18 and 32 – a simple measure of weight for height.
- You weigh at least 110 pounds (50 kg) if you are male, or 99 pounds (45 kg) if you are female.
- You have not had major surgery in the past 12 weeks and do not have any planned during the study.
- You are able to swallow pills without difficulty.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests a new investigational drug to see if it is safe and how the body processes it. It is for healthy adults who are willing to participate in a closely monitored clinical trial.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This trial is testing a new medication called DW4421. It's an early-stage study to see how safe the drug is and how it affects healthy people. Participants will receive the drug multiple times to help doctors understand dosing.
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.